F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Lenvatinib

1	Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma 1/11/2024 5:28:09 AM \| Browse: 92 \| Download: 124
2	Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma 3/10/2023 7:29:15 AM \| Browse: 135 \| Download: 368
3	Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review 7/14/2022 8:05:03 AM \| Browse: 305 \| Download: 908
4	Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment 7/13/2022 7:31:00 AM \| Browse: 246 \| Download: 579
5	Combination therapy (toripalimab and lenvatinib)-associated toxic epidermal necrolysis in a patient with metastatic liver cancer: A case report 4/8/2022 12:06:55 PM \| Browse: 259 \| Download: 511
6	Successful treatment with laparoscopic surgery and sequential multikinase inhibitor therapy for hepatocellular carcinoma: A case report 3/25/2022 2:25:11 PM \| Browse: 325 \| Download: 842
7	Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy 12/14/2021 11:58:13 PM \| Browse: 278 \| Download: 719
8	Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma 12/14/2021 11:58:13 PM \| Browse: 323 \| Download: 741
9	Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma 9/18/2021 1:32:04 PM \| Browse: 339 \| Download: 482
10	Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials 5/13/2021 10:05:39 AM \| Browse: 399 \| Download: 823
11	Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report 4/20/2021 12:49:51 PM \| Browse: 457 \| Download: 592
12	Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report 3/20/2021 2:13:53 AM \| Browse: 424 \| Download: 829
13	Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report 12/18/2020 5:58:43 AM \| Browse: 522 \| Download: 743
14	Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China 8/14/2020 12:33:31 PM \| Browse: 703 \| Download: 1875
15	Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports 6/24/2020 7:33:17 AM \| Browse: 579 \| Download: 999
16	Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma 5/20/2019 9:05:36 AM \| Browse: 634 \| Download: 1101
17	Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond 2/21/2019 9:31:55 AM \| Browse: 1002 \| Download: 947
18	Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma 5/15/2018 7:28:22 AM \| Browse: 1024 \| Download: 1234

Page 1 of 1 ( 18 items )
<<
1
>>

Write to the Help Desk

© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345